Scholarlink

Background <p>Attenuation Imaging (ATI) and controlled attenuation parameter (CAP) are non-invasive ultrasound-based methods for diagnosing hepatic steatosis. However, reports on the clinical usefulness of ATI are limited. We aimed to compare the ability of ATI and CAP to diagnose hepatic steatosis with magnetic resonance imaging–based proton density fat fraction (MRI-PDFF) as the reference standard.</p> Methods <p>We performed a prospective multicenter study of 562 patients with chronic liver disease who underwent ATI, CAP, and MRI-PDFF. Patients with skin-to-liver capsule distance (SCD) ≤ 25&#xa0;mm underwent CAP with an M probe; those with SCD &gt; 25&#xa0;mm underwent CAP with an XL probe. MRI-PDFF was used as the reference standard: S0 corresponds to MRI-PDFF &lt; 5.2%, S1 to 5.2% ≤ MRI-PDFF &lt; 11.3%, S2 to 11.3% ≤ MRI-PDFF &lt; 17.1%, and S3 to MRI-PDFF ≥ 17.1%.</p> Results <p>The correlation coefficients for ATI and MRI-PDFF stratified by body mass index (&lt; 30, ≥ 30&#xa0;kg/m<sup>2</sup>), SCD (&lt; 25, ≥ 25&#xa0;mm), 2-dimensional share wave elastography (&lt; 1.8&#xa0;m/s), fibrosis-4 index (≤ 2.67), albumin–bilirubin score (&lt; − 2.60) and type IV collagen 7&#xa0;s (&lt; 5.0&#xa0;ng/ml) were significantly higher than those for CAP and MRI-PDFF. Areas under the receiver operating characteristics (95% CI) for ATI and CAP were 0.895 (0.869–0.922) and 0.845 (0.809–0.881) for ≥ S1 steatosis, 0.944 (0.926–0.963) and 0.881(0.852–0.910) for ≥ S2 steatosis, and 0.928 (95% CI 0.906–0.950) and 0.860 (95% CI 0.829–0.890) for S3 steatosis. ATI had higher diagnostic performance for all hepatic steatosis grades than CAP.</p> Conclusions <p>ATI is a more useful non-invasive method for diagnosing hepatic steatosis than CAP.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicenter study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年2月24日

查看全文
  • Takashi Nishimura,
  • Toshifumi Tada,
  • Tomoyuki Akita,
  • Reiichiro Kondo,
  • Yasuaki Suzuki,
  • Kento Imajo,
  • Shigehiro Kokubu,
  • Tamami Abe,
  • Hidekatsu Kuroda,
  • Masashi Hirooka,
  • Yoichi Hiasa,
  • Asako Nogami,
  • Atsushi Nakajima,
  • Sadanobu Ogawa,
  • Hidenori Toyoda,
  • Satoshi Oeda,
  • Hirokazu Takahashi,
  • Yuichiro Eguchi,
  • Katsutoshi Sugimoto,
  • Hirohisa Yano,
  • Junko Tanaka,
  • Fuminori Moriyasu,
  • Masayoshi Kage,
  • Takashi Kumada,
  • Hiroko Iijima

摘要

Background

Attenuation Imaging (ATI) and controlled attenuation parameter (CAP) are non-invasive ultrasound-based methods for diagnosing hepatic steatosis. However, reports on the clinical usefulness of ATI are limited. We aimed to compare the ability of ATI and CAP to diagnose hepatic steatosis with magnetic resonance imaging–based proton density fat fraction (MRI-PDFF) as the reference standard.

Methods

We performed a prospective multicenter study of 562 patients with chronic liver disease who underwent ATI, CAP, and MRI-PDFF. Patients with skin-to-liver capsule distance (SCD) ≤ 25 mm underwent CAP with an M probe; those with SCD > 25 mm underwent CAP with an XL probe. MRI-PDFF was used as the reference standard: S0 corresponds to MRI-PDFF < 5.2%, S1 to 5.2% ≤ MRI-PDFF < 11.3%, S2 to 11.3% ≤ MRI-PDFF < 17.1%, and S3 to MRI-PDFF ≥ 17.1%.

Results

The correlation coefficients for ATI and MRI-PDFF stratified by body mass index (< 30, ≥ 30 kg/m2), SCD (< 25, ≥ 25 mm), 2-dimensional share wave elastography (< 1.8 m/s), fibrosis-4 index (≤ 2.67), albumin–bilirubin score (< − 2.60) and type IV collagen 7 s (< 5.0 ng/ml) were significantly higher than those for CAP and MRI-PDFF. Areas under the receiver operating characteristics (95% CI) for ATI and CAP were 0.895 (0.869–0.922) and 0.845 (0.809–0.881) for ≥ S1 steatosis, 0.944 (0.926–0.963) and 0.881(0.852–0.910) for ≥ S2 steatosis, and 0.928 (95% CI 0.906–0.950) and 0.860 (95% CI 0.829–0.890) for S3 steatosis. ATI had higher diagnostic performance for all hepatic steatosis grades than CAP.

Conclusions

ATI is a more useful non-invasive method for diagnosing hepatic steatosis than CAP.